Cargando…
Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction
BACKGROUND: Cardiovascular diseases (CVDs) are the leading causes of mortality worldwide. Currently, the best treatment options for myocardial infarction focus on the restoration of blood flow as soon as possible, which include reperfusion therapy, percutaneous coronary intervention, and therapeutic...
Autores principales: | Zhang, Shouwen, Li, Jingfang, Hu, Shunpeng, Wu, Fangfang, Zhang, Xianzhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045899/ https://www.ncbi.nlm.nih.gov/pubmed/30022826 http://dx.doi.org/10.2147/IJN.S165590 |
Ejemplares similares
-
Biological fate and interaction with cytochromes P450 of the nanocarrier material, d-α-tocopheryl polyethylene glycol 1000 succinate
por: Ren, Tianming, et al.
Publicado: (2022) -
Development and evaluation of vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical
por: Shen, Roger, et al.
Publicado: (2016) -
Iron Transport Tocopheryl Polyethylene Glycol Succinate in Animal Health and Diseases
por: Srivastava, Ajay, et al.
Publicado: (2019) -
Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions
por: Sun, Deqing, et al.
Publicado: (2014) -
Nanoparticles of Poly(Lactide-Co-Glycolide)-d-a-Tocopheryl Polyethylene Glycol 1000 Succinate Random Copolymer for Cancer Treatment
por: Ma, Yuandong, et al.
Publicado: (2010)